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Torsades de pointes (TdP) liability is a stochastic event, which indicates that unidentified factors have an important role in
facilitating the initiation of TdP by increasing the probability of TdP occurrence. We sought to identify factors that facilitate
drug-induced TdP.
EXPERIMENTAL APPROACH
We studied dofetilide-induced TdP in pentobarbital-anaesthetized, phenylephrine-sensitized rabbits, seeking biomarkers that
discriminated between the animals that experienced TdP (‘TdP+’ animals) and those that did not (‘TdP-’ animals). As novel
variables, the beat-to-beat variability and instability of ECG intervals were measured at preset times, irrespective of whether or
not hearts were in stable sinus rhythm (‘absolute’ variability and instability). Autonomic activity was also determined.
KEY RESULTS
Dofetilide delayed repolarization and induced arrhythmias prior to TdP. The variability of the coupling interval and shape of
arrhythmic beats before TdP were significantly greater in the ‘TdP+’ group than in the ‘TdP-’ group. Accordingly, the
‘absolute’ variability and instability of the ECG intervals were significantly elevated in the ‘TdP+’ group. Phenylephrine
increased significantly the up-baroreflex sensitivity in the ‘TdP+’ group before dofetilide administration.
CONCLUSIONS AND IMPLICATIONS
‘Preceding’ arrhythmias have characteristics that permit prediction of TdP occurrence: the more chaotic the ventricular
rhythm, the greater the probability of TdP initiation. This suggests that complexity of the arrhythmic beats may play an
important mechanistic role in TdP genesis. The electrical instability quantified by the novel ‘absolute’ variability and instability
parameters correlates with the probability of TdP occurrence. Baroreflex may contribute to TdP genesis in vivo.
Abbreviations
BRS, baroreflex sensitivity; DI, ventricular electric diastolic interval; ECG, electrocardiogram; IKr, the rapid component of
the delayed rectifier potassium current; LTI, long-term instability; LTV, long-term variability; QTc, heart rate-corrected
QT interval; RMS, root mean square; RMSSD, root mean square of the successive differences; SDSD, standard deviation
of the successive differences; STI, short-term instability; STV, short-term variability; TdP, torsades de pointes; TI, total
instability; Tpeak–Tend, the period between the peak and the end of T wave
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Introduction
The pro-arrhythmic liability of any drug under
development must be assessed to minimize the risk
of life-threatening drug-induced arrhythmias, such
as torsades de pointes (TdP) during pharmaco-
therapy (Farkas and Nattel, 2010).
The most commonly used animal model for
the in vivo screening for TdP liability is the
a1-adrenoceptor-stimulated anaesthetized rabbit
model developed by Carlsson et al. (1990). In this
model, the ability of a test agent to evoke TdP is
evaluated during co-administration of a ‘priming’
substance, the selective a1-adrenoceptor agonist
methoxamine (Carlsson et al., 1990) or phenyleph-
rine (Farkas et al., 1998; 2002). The role of the
priming a1-adrenoceptor stimulation is not com-
pletely understood. Interestingly, co-administration
of the selective inhibitor of the rapid component of
the delayed rectifier K+ current (IKr) dofetilide and
the a1-adrenoceptor agonist methoxamine only
infrequently evoked TdP in isolated rabbit hearts
(Farkas et al., 2006). This has three important
caveats. First, in vivo factors may have a crucial role
in assisting the genesis of TdP and one of the pos-
sible contributors to genesis of TdP in vivo is the
autonomic nervous system. A recent study revealed
that bilateral vagotomy prevented drug-induced
TdP in anaesthetized rabbits (Farkas et al., 2008).
Second, it predicates the use of surrogate biomark-
ers for TdP. Indeed, surrogate biomarkers such as
QT prolongation are pre-eminent in TdP liability
testing, to the extent that most methodological
approaches combine multiple biomarkers in an
integrated risk assessment (Pugsley et al., 2008).
Third, in this and all TdP liability tests, it is not
possible to predict precisely whether or not TdP
will occur in any individual animal or isolated
heart. This shows that TdP liability is a stochastic
event, and indicates that hitherto unidentified
factors have an important role in facilitating the
initiation of TdP (by increasing the probability of
TdP occurrence).
The aim of the present study was to identify
factors that facilitate the initiation of drug-induced
TdP. We selected dofetilide-induced TdP in anaes-
thetized, a1-adrenoceptor-stimulated rabbits, as this
is perhaps one of the most extensively studied con-
ditions for TdP (i.e. model plus drug). The approach
was to identify the biomarkers and the endogenous
determinants of TdP that best discriminated
between the animals that experienced TdP (‘TdP+’
animals) and those that did not (‘TdP-’ animals).
For completeness we included relevant variables
including basic haemodynamics, blood gases,
repolarization-related parameters, arrhythmias prior
to TdP and activity of the autonomic nervous
system in the analysis.
Methods
Animals
Animals were handled in accordance with the Euro-
pean Community guidelines for the use of experi-
mental animals, and the protocol was reviewed and
approved by the Ethical Committee for the Protec-
tion of Animals in Research at the University of
Szeged, Hungary. The pro-arrhythmic activity of
dofetilide was examined by using the in vivo method
of Carlsson et al. (1990) with minor modifications
(Vincze et al., 2008). The experiments were per-
formed on female New Zealand White rabbits
weighing 2.7  0.04 kg (n = 30).
Anaesthesia
A catheter was introduced into the marginal vein of
the left ear for blood sampling and induction of
anaesthesia. One millilitre of blood was withdrawn
via the catheter to determine serum ion (K+, Na+ and
Ca2+) concentrations in the conscious animal. After
blood sampling, the animals were anaesthetized
with pentobarbital (i.v.). In accordance with our
previous study (Vincze et al., 2008), the depth of
anaesthesia was carefully assessed throughout the
experiment. Surgery started when the pedal with-
drawal reflex had disappeared and there was no
response to pinching of the ears. The dose of anaes-
thetic was adjusted to the need of the animal. When
there was any sign of pain or consciousness, extra
bolus of 6–9 mg pentobarbital was administered.
The dose of pentobarbital needed for sufficiently
deep anaesthesia was 53  2 mg·kg-1 (at a rate of
30 mg·mL-1·min-1). The rabbits were retrospectively
divided into two groups according to the presence
or the absence of TdP, that is, the animals that
experienced TdP formed the ‘TdP+’ group, and the
animals that did not experience this arrhythmia
formed the ‘TdP-’ group. The administered doses of
pentobarbital did not differ significantly between
the ‘TdP+’ and the ‘TdP-’ groups (55  2 mg·kg-1
and 49  2 mg·kg-1 respectively). When anaesthesia
was not deep enough after induction and there was
any sign of pain or consciousness, an extra bolus of
pentobarbital was administered (to two rabbits): 7
and 4.3 mg·kg-1 respectively.
Surgical preparation
A catheter was introduced into the right carotid
artery to measure blood pressure and to withdraw
arterial blood for blood gas analysis. The catheter
was filled with heparin/saline (0.9% w/v NaCl
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containing 15 I.U.·mL-1 heparin) and connected to a
pressure transducer of a National Instruments data
acquisition hardware (PC card, National Instru-
ments, Austin, TX, USA) using SPEL Advanced Hae-
mosys software (version 2.76, Experimetria Ltd. and
Logirex Software Laboratory, Budapest, Hungary).
Blood pressure was recorded at a sampling rate of
1000 Hz. Catheters were introduced into the right
jugular vein and the marginal vein of the right ear
for the infusion of drugs. After tracheal cannulation,
artificial ventilation was started (Harvard rodent
ventilator, model 683, Harvard Apparatus, South
Natick, MA, USA) with room air at a rate of 40
strokes·min-1, a stroke volume of ~6 mL·(kg body
weight)-1 and a positive end-expiratory pressure of
1–2 cm H2O. Blood gases were monitored with a Stat
Profile® Critical Care Xpress pH/blood gas analyser
(Nova Biomedical, Waltham, MA, USA). If necessary,
the stroke volume of the ventilation pump and the
positive end-expiratory pressure were adjusted to
maintain the blood gases within the normal range.
Subcutaneous needle electrodes were inserted in all
four limbs, and leads I, II and III of the ECG were
recorded simultaneously at a sampling rate of
1000 Hz with the National Instruments system. The
preparation was followed by a minimum 10 min
stabilizing period.
Experimental protocol
After a 10 min baseline period, a1-adrenoceptor
agonist phenylephrine infusion was started intra-
venously at increasing rates (i.e. 3, 6, 9, 12 and
15 mg·kg-1·min-1 for 3, 3, 3, 3 and 5 min respec-
tively). From the 27th minute, dofetilide
(0.02 mg·kg-1·min-1 i.v., for 30 min) was adminis-
tered simultaneously with the background phenyle-
phrine infusion (at a rate of 15 mg·kg-1·min-1) until
the end of the experiments (Figure 1). The selective
IKr inhibitor dofetilide was chosen as its TdP liability
is well established in humans (Pedersen et al., 2007)
and in experimental models (Farkas et al., 2006;
Vincze et al., 2008). The infusion rate of dofetilide
was chosen as this rate of the dofetilide infusion
induced TdP approximately in half of rabbits in a
pilot study.
In a recent study we found that dofetilide infu-
sion at a rate of 0.04 mg·kg-1·min-1 induced TdP in
40% of rabbits anaesthetized with Na-pentobarbital
(Vincze et al., 2008). In contrast, dofetilide at a rate
of 0.02 mg·kg-1·min-1 induced TdP in 67% of the
rabbits anaesthetized with Na-pentobarbital in the
present study. This difference in TdP incidence
between the two studies may be due to not fully
identical experimental settings in the two studies
(e.g. different experimenter, laboratory, time and
source of dofetilide). However, the conclusions
of the present study and Vincze et al. (Vincze
et al., 2008) are not influenced by this difference
in TdP incidence, as within-study experimental
settings were standard in these two independent
investigations.
ECG analysis
After completing experiments the ECG was replayed
and the arrhythmia incidences, the time to onset,
and the duration of ventricular arrhythmias were
obtained by a skilled expert. After completing
arrhythmia analysis, the experiments were encoded
and the ECG intervals (RR, PQ, QRS, QT and Tpeak–
Tend) were measured by the same expert in a blinded
and prospective manner without the knowledge
that the actual animal did or did not experience TdP
later in the course of the experiment.
The blood pressure and the ECG intervals were
measured at predetermined time points. The RR, PQ,
QRS, QT and Tpeak–Tend intervals were measured by
the manual positioning of on-screen markers. The
QT interval measurement was performed as we
described previously (Farkas et al., 2004). Briefly, the
QT interval was defined as the time between the first
deviation from the isoelectric line during the PQ
Figure 1
Drug administration protocol. Phenylephrine is administered at
increasing rates (3, 6, 9, 12 and 15 mg·kg-1·min-1). Dofetilide is
infused at a rate of 0.02 mg·kg-1·min-1. Segments indicate the unin-
terrupted periods of the measurement of sympathetic (Sy) and para-
sympathetic (Psy) activity. ECG variability and instability parameter
measurements were performed at four time points indicated with
upward, dashed arrows. Baseline, value determined from 40 con-
secutive ventricular beats before drug administration; Phe, value
determined from 40 consecutive ventricular beats in the last minute
of the 15 mg·kg-1·min-1 phenylephrine infusion rate before the start
of dofetilide infusion; Dof, the value determined from 40 consecutive
RR intervals shortly after the beginning of the dofetilide infusion in
the 2nd–4th minutes of dofetilide infusion (‘Sinus’ variability and
instability) or in the 4th minute of dofetilide infusion (‘Absolute’
variability and instability); Bef TdP, the value measured from 40
consecutive ventricular beats immediately before TdP occurred in the
‘TdP+’ group of animals or at an equivalent time point in the ‘TdP-’
group of animals.
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interval until the end of the TU wave. The T (or U)
wave frequently overlapped the P wave of the fol-
lowing sinus-origin beat, due to the relatively high
heart rate of the rabbit or to substantial QT prolon-
gation. In these cases, the extrapolation method was
used (Farkas et al., 2004), that is, the end of the TU
wave was extrapolated from the curve of the TU
wave to the isoelectric line under the P wave. All the
values for the QT interval were corrected for the
heart rate with the equation QTcL = QT - 0.704
(RR-250) developed for pentobarbital-anaesthetized
rabbits (Batey and Coker, 2002). Duration of the JT
interval was subsequently calculated by subtraction
of the QRS interval from the corresponding QT
interval. The ventricular electric diastolic interval
was defined as the time between the end of the TU
wave until the beginning of the following QRS
complex. When the end of the TU wave was
chopped off by the subsequent QRS complex, due to
substantial QT prolongation or to occurrence of an
R-on-T phenomenon, then ventricular electric dias-
tolic interval was arbitrarily taken as 0.000001 ms
(not 0 ms). The Tpeak–Tend interval was measured in
the standard limb lead II of the ECG in the last
minute before the start of the phenylephrine infu-
sion (baseline), in the last minute before the start of
the dofetilide infusion and in the 4th minute of the
dofetilide infusion (further measurements were pre-
vented by the frequent occurrence of dofetilide-
induced arrhythmias). When the end of the Tpeak–
Tend interval overlapped the following P wave, the
extrapolation method (Farkas et al., 2004) was
applied. Four consecutive Tpeak–Tend intervals were
measured and averaged at each time point.
The T-wave lability was quantified as a root mean
square of the differences in the voltage between
corresponding signal values of subsequent beats.
The magnitude of aperiodic T-wave lability was
quantified by measuring a T-wave lability index
with a computer program developed by us following
the descriptions of Nemec et al. (2003).
Arrhythmia diagnosis
Ventricular premature beat, bigeminy, salvo and
ventricular fibrillation were defined according to the
Lambeth Conventions (Walker et al., 1988). When
continuous ventricular fibrillation lasted longer
than 120 s, the experiment was terminated and the
ventricular fibrillation was defined as lethal. TdP
was defined as a polymorphic ventricular tachycar-
dia consisting of four or more ventricular complexes
where clear twisting of the QRS complexes around
the isoelectric axis could be seen in at least one ECG
lead (Figure 2). Runs of four or more ventricular
premature beats without the TdP-like twisting QRS
morphology were differentiated from TdP and were
defined as ventricular tachycardia (Figure 2). Blocks
in the conduction system were also monitored.
Figure 2
An example of dofetilide-induced torsades de pointes ventricular tachycardia (TdP). ECG and arterial blood pressure signals recorded before drug
administration (A), in the last minute of the 15 mg·kg-1·min-1 phenylephrine infusion rate before the start of dofetilide infusion (B) and during
dofetilide infusion immediately before the first run of TdP occurred (C). ECG I–III, electrocardiogram leads I–III; BP, arterial blood pressure signal
recorded in the right carotid artery; VPB, ventricular premature beat; VT, ventricular tachycardia different from TdP; S, sinus beat. Note the chaotic
ventricular rhythm and the corresponding, haemodynamically non-compromising, irregular fluctuation in the blood pressure before TdP.
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Conduction disturbances included atrioventricular
blocks and intraventricular conduction defects
(right or left bundle branch blocks).
Measurement of the beat-to-beat variability
and instability of the ECG intervals: ‘sinus’
and ‘absolute’ variability and instability
The ‘sinus’ beat-to-beat variability and instability of
the RR and QT intervals were determined from the
manual measurement data on 40 consecutive RR
intervals and the corresponding QT intervals in
sinus rhythm (‘sinus’ variability and instability) in
the last minute of the drug-free state, in the last
minute of the phenylephrine infusion before the
dofetilide administration and in the 2nd–4th
minutes of the dofetilide infusion, when arrhyth-
mias were still infrequent.
The ‘absolute’ beat-to-beat variability and insta-
bility of the RR, QRS, JT, QT and electric diastolic
intervals were determined irrespective of the pres-
ence or absence of sinus rhythm from manual mea-
surement data on 40 consecutive RR intervals and
the corresponding QRS and QT intervals at prede-
termined time points, that is, in the last minute of
the drug-free state, in the last minute of the phe-
nylephrine infusion before the dofetilide adminis-
tration and in the 4th minute of the dofetilide
infusion. The ‘absolute’ beat-to-beat variability and
instability of the RR, QRS, JT, QT and electric dias-
tolic interval were also determined at a 4th time
point immediately before TdP occurred in the ‘TdP+’
group of animals or at an equivalent time point in
the rabbits that did not experience TdP (700 s after
the start of dofetilide infusion in the ‘TdP-’ group of
animals). That is, 40 consecutive ventricular cycles
(RR intervals and contemporaneous QRS and QT
intervals) were measured regardless of rhythm at the
predetermined time point. In case of arrhythmic
ventricular beats, the QT interval was defined as the
time between the start of the QRS complex of the
arrhythmic ventricular beat until the end of the T
wave (or U wave, when it was present). The T (or U)
wave frequently overlapped the P wave of the fol-
lowing sinus-origin beat, due to the relatively high
heart rate of the rabbit or to substantial QT prolon-
gation. In these cases, the extrapolation method was
used (Farkas et al., 2004), that is, the end of the TU
wave was extrapolated from the curve of the TU
wave to the isoelectric line under the P wave. The
extrapolation method was also used in order to
measure the length of the QT interval when the end
of the TU wave was chopped off by the subsequent
QRS complex, due to substantial QT prolongation or
to occurrence of an R-on-T phenomenon. In these
cases, the end of the TU wave was extrapolated from
the curve of the TU wave to the isoelectric line
through the subsequent QRS complex.
All of the beat-to-beat variability and instability
parameters of the RR and QT intervals were deter-
mined in a blinded and prospective manner at the
first three time points (see above). Measurement of
the ‘absolute’ beat-to-beat variability and instability
of the RR and QT intervals at the 4th time point
(immediately before TdP occurred or at the mean
TdP onset time) was performed subsequently in an
unblinded manner.
We developed a computer program in a .NET
environment to obtain the following parameters of
the beat-to-beat variability and instability of the RR,
QRS, JT, QT and electric diastolic intervals: the ‘root
mean square’ for a sequence of RR, QRS, JT, QT and
electric diastolic interval durations, the ‘root mean
square’ and the ‘standard deviation’ of the succes-
sive differences of the RR, QRS, JT, QT and electric
diastolic intervals, the ‘Instability’ of the RR, QRS,
JT, QT and electric diastolic intervals, the ‘short-
term variability’ (STV) and the ‘long-term variabil-
ity’ (LTV) were calculated as described earlier
(Hondeghem et al., 2001; Thomsen et al., 2004;
Vincze et al., 2008; Farkas et al., 2009). We also cal-
culated the ‘total instability’, the ‘short-term insta-
bility’ and the ‘long-term instability’ (LTI) of the
consecutive RR, QRS, JT, QT and electric diastolic
intervals as described previously (van der Linde
et al., 2005).
Characterization of the arrhythmic beats
during dofetilide administration
The multiplicity of the arrhythmic beats was quan-
tified by measuring the coupling interval, the R
voltage and the duration of the QRS interval from
manual measurement data on the first 40 arrhyth-
mic beats after the start of dofetilide infusion and
the last 40 arrhythmic beats immediately before TdP
occurrence (or at equivalent time point in the ‘TdP-’
group of animals). The R wave of the QRS complex
was defined as the wave with the greatest deflection
from the isoelectric line within the QRS complex; R
wave was regarded as a negative wave, when the
greatest deflection of the QRS complex was negative.
Coupling interval was defined as the distance
between the peak of the R wave of the arrhythmic
beat and the peak of the R wave of the preceding
QRS complex. R voltage was defined as the voltage
of the peak of the R wave from the isoelectric line.
Duration of the QRS interval of the arrhythmic beat
was defined as the interval from the first deflection
of the QRS complex until the J point. Within-animal
mean and within-animal standard deviation of the
coupling intervals, the R voltages and the QRS
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durations measured on 40 arrhythmic beats were
calculated at every time point in every animal.
Assessing vagal nerve activity and
sympathetic activity in sinus rhythm
In order to assess vagal nerve activity, the beat-to-
beat variability of the RR interval and the baroreflex
sensitivity (BRS) of the spontaneous baroreflex
sequences were analysed with a computer software
(WinCPRS; Absolute Aliens Oy, Turku, Finland) as
described earlier (Vincze et al., 2008). The analysis
was performed in the corresponding ECG section
and the arterial blood pressure signal of the last
5 min of the drug-free period before the phenyleph-
rine infusion and the last 1 min of each rate
of phenylephrine infusion before the dofetilide
administration (see Experimental protocol and
Figure 1). Only the arrhythmia-free ECG sections
with uninterrupted sinus rhythm were analysed
(Figure 3), that is, if any arrhythmia occurred within
the analysed 5-min- or 1-min-long period at the
time point of the measurement, then the whole
period was excluded from the analysis. The software
calculated the mean and the standard deviation of
the RR intervals together with root mean square of
the successive differences (see above) and the mean
‘up’ and ‘down’ BRS within a given experimental
period.
The spectral power of the systolic arterial
pressure was calculated in the frequency range 0.15–
0.5 Hz (mid-frequency range) to assess the sympa-
thetic activity as we described recently (Vincze et al.,
2008). Spectral analysis was performed in the last
5 min of the drug-free period and the 3 min of the
9 mg·kg-1·min-1 phenylephrine infusion rate. Only
the arrhythmia-free, uninterrupted periods were
analysed, that is, if any arrhythmia occurred within
the analysed 5-min- or 3-min-long period at the
time point of the measurement, then the whole
period was excluded from the analysis.
Statistical evaluation
Continuous data were expressed as mean  stan-
dard error of the mean (SEM). All data from inde-
pendent samples, with the exception of arrhythmia
incidences, were compared with Kruskal–Wallis
tests. Continuous data from the same sample were
compared with Wilcoxon tests. Arrhythmia inci-
dences were compared by using the Fisher’s exact
probability test. Differences were considered statis-
tically significant when P < 0.05.
Materials
Dofetilide was a generous gift from Gedeon Richter
PLC. (Budapest, Hungary). The sources of all other
drugs and the preparation of drug solutions were
Figure 3
A representative example of the 115 arrhythmia-free, 1-min-long periods used for computerized analysis of the heart rate variability and the
baroreflex sensitivity (BRS) during phenylephrine infusion. The period was recorded at the last minute of the highest rate of phenylephrine infusion
(15 mg·kg-1·min-1) immediately before the start of dofetilide infusion in an animal that experienced TdP later, during dofetilide infusion. Table 5
contains the typical up- and down-BRS values calculated from the spontaneous baroreflex sequences identified within the period. Min, minimum;
max, maximum; SD, standard deviation; Valid: the percentage incidence of RR intervals displaying spontaneous baroreflex sequences used to
calculate BRS data.
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described in detail earlier (Vincze et al., 2008). Drug
and receptor nomenclature follows Alexander et al.
(2009).
Results
Arrhythmia incidences, frequency of
arrhythmic beats and onset time
of arrhythmias
Torsades de pointes occurred in 20 out of 30 animals
(Table 1). The rabbits were retrospectively divided
into two groups according to the presence or the
absence of TdP, that is, the animals that experienced
TdP formed the ‘TdP+’ group (n = 20 animals), and
the animals that did not experience this arrhythmia
formed the ‘TdP-’ group (n = 10 animals) (Table 1).
Arrhythmias (mostly ventricular premature
beats) occurred in some animals during phenyleph-
rine administration before dofetilide infusion
(Table 1). However, most of the arrhythmia inci-
dences were low during phenylephrine infusion,
which allowed us to detect the pro-arrhythmic
effects of dofetilide infusion. There was no signifi-
cant difference in the group incidence of arrhyth-
mias between the ‘TdP+’ and ‘TdP-’ groups of
animals before dofetilide administration (Table 1);
TdP and ventricular fibrillation did not occur before
dofetilide infusion. Dofetilide strikingly increased
the group incidence of arrhythmias in both groups.
Interestingly, not only the incidence of TdP, but also
the incidence of non-TdP type ventricular tachycar-
dia was significantly higher in the ‘TdP+’ group than
in the ‘TdP-’ group during dofetilide infusion. TdP
degenerated into sustained ventricular fibrillation
leading to death in three animals (15%) in the
‘TdP+’ group (Table 1).
The per cent frequency of arrhythmic beats was
calculated within the period of the 40 ventricular
cycles used for measurement of the ‘absolute’ beat-
to-beat variability and instability parameters
(number of arrhythmic beats per 40 beats times
100). There was no statistical difference in the fre-
quency of arrhythmic beats before dofetilide admin-
istration between the ‘TdP+’ and ‘TdP-’ groups of
animals (Figure 4A). Dofetilide infusion strikingly
increased the frequency of arrhythmic beats during
the course of its infusion in both the ‘TdP+’ and
‘TdP-’ groups of animals. After 3 min of dofetilide
infusion (at the 3rd time point), the frequency
of arrhythmic beats were significantly higher in
the ‘TdP+’ group than that in the ‘TdP-’ group
(Figure 4A). Later, as the number of ventricular
arrhythmias increased further, the difference in the
frequency of arrhythmic beats became insignificant
between the ‘TdP+’ and ‘TdP-’ groups at the 4th
time point, immediately before TdP occurred in the
‘TdP+’ group of animals (Figure 4A).
Dofetilide infusion caused a cascade in arrhyth-
mia development in every ‘TdP+’ animal; not only
the number of arrhythmias, but also the complexity
of arrhythmias increased during the course of
dofetilide infusion. That is, the arrhythmia onset
followed a progressive order: the earliest arrhythmia
to occur was ventricular premature beat, then salvo
came, later non-TdP type ventricular tachycardia
occurred, finally TdP developed (Figure 4B). In fact,
the final and most complex arrhythmia was ven-
tricular fibrillation to occur during dofetilide infu-
sion but it occurred only in 3 out of 20 ‘TdP+’
Table 1
Per cent incidence of arrhythmias before and during dofetilide infusion in anaesthetized rabbits
n
Incidence of arrhythmias (%)
VPB BG Salvo Block VT TdP VF
Before dofetilide
TdP- 10 30 20 20 0 10 0 0
TdP+ 20 65 45 35 10 15 0 0
During dofetilide
TdP- 10 90 80 90 60 40 0 0
TdP+ 20 100 95 100 90 100* 100* 15
Values are percentage incidences of arrhythmias.
*P < 0.05 as compared with the ‘TdP-’ group, Kruskal–Wallis test.
Before dofetilide, the drug-free period and period when only phenylephrine infusion was administered; During dofetilide, the period when
phenylephrine and dofetilide infusions were administered simultaneously. TdP-, group of animals not experiencing torsades de pointes during
the experiment; TdP+, group of animals experiencing torsades de pointes during the experiment; VPB, ventricular premature beat; BG,
bigeminy; Block, conduction block of any kind; VT, ventricular tachycardia different from torsades de pointes; TdP, torsades de pointes; VF,
ventricular fibrillation; n, group size.
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animals, whereas all the other less complex arrhyth-
mias occurred in every ‘TdP+’ animal. There was no
statistical difference in the onset times of ventricular
premature beat, salvo and non-TdP type ventricular
tachycardia between the ‘TdP+’ and the ‘TdP-’
groups (data not shown). The cumulative dose
of dofetilide that triggered TdP was 0.23 
0.03 mg·kg-1 and TdP occurred at 699  97 s after
the start of dofetilide infusion.
Blood pressure
The baseline systolic and diastolic arterial blood
pressure values did not differ between the ‘TdP+’
and the ‘TdP-’ groups (Table 2). The stepwise eleva-
tion of the rate of infusion of phenylephrine
increased the blood pressure. Arrhythmias occurred
frequently in all animals approximately 4 min after
the start of dofetilide administration, which pre-
vented measurement of the blood pressure in sinus
rhythm thereafter. There was no significant differ-
ence in the blood pressure values between the ‘TdP+’
and the ‘TdP-’ groups at any time point.
Heart rate and ECG intervals in sinus rhythm
Phenylephrine reduced sinus heart rate (Tables 2
and 3) and prolonged the QT interval equally in
both groups before the dofetilide infusion (Tables 2
and 4). Arrhythmias occurred frequently in all
animals approximately 4 min after the start of the
dofetilide administration, which prevented mea-
surement of the sinus heart rate and the ‘sinus’ ECG
intervals thereafter.
Dofetilide prolonged the QT (Table 2) and the
rate-corrected QT intervals (QTc) in the ‘TdP+’ and
the ‘TdP-’ groups up until the time point at which
these intervals could be measured (see above). There
was no significant difference in the QT and the QTc
intervals between the ‘TdP+’ and the ‘TdP-’ groups,
when QT interval was measured in sinus rhythm.
There was no qualitative difference in the effects of
the drugs on the QT and the QTc intervals at any
time point in both the ‘TdP+’ and the ‘TdP-’ groups,
thus QTc data are not shown.
There was no significant difference in the Tpeak–
Tend intervals between the ‘TdP+’ and the ‘TdP-’
groups at any of the three time points of the mea-
surement (Table 2). The mean baseline ‘sinus’ PQ
interval was 50  1 ms in ‘TdP+’ and the ‘TdP-’
groups; the mean baseline ‘sinus’ QRS interval was
47  1 ms and 49  3 ms in the ‘TdP+’ and the
‘TdP-’ groups respectively. The ‘sinus’ PQ and QRS
intervals remained stable up until the time point at
which these could no longer be measured (4 min of
dofetilide infusion); there were no statistical differ-
ences in the ‘sinus’ PQ or QRS intervals between the
‘TdP+’ and the ‘TdP-’ groups at any time point of
the measurement (data not shown).
T-wave lability index could be measured only
until the end of phenylephrine infusion, as dofetil-
ide evoked many arrhythmias, which did not allow
assessment of 100 subsequent T waves during
normal sinus rate. Phenylephrine slightly increased
the T-wave lability index in the ‘TdP+’ group, but
the change was not significant (Table 2).
Beat-to-beat variability and instability of the
RR and the QT intervals in sinus rhythm
There was a small, but significant increase in the
‘sinus’ beat-to-beat variability and instability of
the RR and QT intervals in the ‘TdP+’ group during
the course of the experiment (Tables 3 and 4);
Figure 4
A: Per cent frequency of arrhythmic beats (AB frequency) in the 40 consecutive ventricular beats at the time point of the measurement (number
of arrhythmic beats per 40 beats times 100). TdP-, group of animals (n = 10) not experiencing torsades de pointes during the experiment; TdP+,
group of animals (n = 20) experiencing torsades de pointes during the experiment. All values shown as means  SEM. *P < 0.05 versus the ‘TdP-’
group, Kruskal–Wallis test. #P < 0.05 Dof versus Phe, Wilcoxon test. The results of within-group comparisons are shown only between the Phe and
Dof time points. For further details, see Figure 1. B: Arrhythmia onset times after the start of dofetilide infusion in the ‘TdP+’ group of animals.
Every onset time was determined in all 20 ‘TdP+’ animals; all values shown as means  SEM. †P < 0.05 versus VPB; ‡P < 0.05 versus Salvo;
#P < 0.05 versus VT, Wilcoxon test. For further details, see Figure 2.
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however, the increase in the ‘sinus’ beat-to-beat
variability and instability of the QT interval was
caused mostly by the phenylephrine infusion prior
to dofetilide administration. Nevertheless, neither
‘sinus’ RR nor ‘sinus’ QT variability and instability
parameters differed significantly between the ‘TdP+’
and ‘TdP-’ groups of animals at baseline, during the
phenylephrine infusion and at the beginning of
the dofetilide infusion (Figures 5 and 6, Tables 3
and 4).
The ‘absolute’ beat-to-beat variability and
instability of the ECG intervals
When the ECG intervals in 40 consecutive cardiac
cycles were analysed irrespective of the presence or
absence of sinus rhythm during the measurement, a
remarkable effect of the drugs was revealed. Phe-
nylephrine infusion increased the ‘absolute’ beat-to-
beat variability and instability of all ECG intervals
as compared with baseline in both the ‘TdP+’ and
the ‘TdP-’ groups, but these parameters did not
differentiate between the ‘TdP+’ and ‘TdP-’ groups
of animals before dofetilide administration
(Figures 5–7, Tables 3 and 4).
Dofetilide progressively increased the ‘absolute’
beat-to-beat variability and instability of the RR and
QT intervals in the ‘TdP+’ and ‘TdP-’ groups, but the
dofetilide-induced increase in these parameters
reached statistical significance only in the ‘TdP+’
group after 3 min of dofetilide infusion (3rd time
point vs. 2nd time point, within-group analysis, Fig-
ures 4 and 5, Tables 3 and 4).
Dofetilide infusion progressively increased the
‘absolute’ beat-to-beat variability and instability
parameters of the RR, QRS, JT, QT and electric dias-
tolic intervals in both the ‘TdP+’ and the ‘TdP-’
groups. Importantly, most of these parameters dif-
ferentiated between the ‘TdP+’ and ‘TdP-’ groups of
animals; that is, the ‘absolute’ beat-to-beat variabil-
ity and instability parameters of the RR, QRS, JT, QT,
and electric diastolic intervals were significantly
greater in the ‘TdP+’ group of animals than in the
‘TdP-’ group of animals immediately before TdP
occurrence (Figures 5–7, Tables 3 and 4). LTV and
LTI were the most sensitive variables out of the
numerous variability and instability parameters we
calculated; ‘absolute’ LTV and ‘absolute’ LTI showed
significant difference in every ECG interval (the RR,
QRS, QT, JT and electric diastolic interval) between
the ‘TdP+’ and the ‘TdP-’ groups of animals imme-
diately before TdP occurrence (Figures 5–7, Tables 3
and 4).
Table 2
Heart rate, QT and Tpeak–Tend intervals, T-wave lability index and arterial blood pressure in anaesthetized rabbits
n 0 min 10 min
Phenylephrine Phe + Dof
13 min 16 min 19 min 22 min 27 min 29 min 31 min
TdP-
HR 10 275  10 275  10 270  10 255  12 253  13 242  15 236  12 229  6 222  23
QT 10 160  4 167  3 163  4 172  5 172  6 184  6 188  7 196  5 213  14
TpTe 10 52  5 58  5 68  7
TWLI 10 0.08  0.02 0.08  0.01 n.d. n.d.
DAP 10 85  5 94  4 99  5 105  4 110  5 114  4 115  3 126  7
SAP 10 110  4 117  3 122  5 129  5 137  5 139  5 143  5 151  6
TdP+
HR 20 285  7 280  7 276  6 258  7 243  7 233  7 231  7 237  12 205  23
QT 20 168  4 166  4 166  4 172  4 177  5 184  6 189  6 187  6 199  15
TpTe 20 51  3 60  5 60  5
TWLI 18 0.08  0.01 0.12  0.02 n.d. n.d.
DAP 20 90  3 93  2 102  3 106  3 109  3 112  4 115  2 111  6
SAP 20 115  3 117  3 126  3 131  4 135  3 139  4 146  4 140  6
All values are means  SEM. There was no significant difference in the respective values of any variable between the ‘TdP+’ and ‘TdP-’ groups
of animals at any time point. For further details, see Table 1.
Phenylephrine, time points when phenylephrine is infused at increasing rates; Phe + Dof, time points when phenylephrine and dofetilide are
infused simultaneously (see Figure 1 for protocol); n, number of animals in which the parameter was determined at 0 or 10 min (n declined
due to arrhythmia occurrence at later time points); HR, sinus heart rate (min-1); QT, the electrocardiographic QT interval (ms); TpTe, the
electrocardiographic Tpeak–Tend interval (ms); TWLI, T-wave lability index; DAP, diastolic arterial pressure (mmHg); SAP, systolic arterial pressure
(mmHg); n.d. not determined.
BJPBiomarkers of torsades de pointes liability
British Journal of Pharmacology (2010) 161 1477–1495 1485
Repolarization prolongation measured by the
‘absolute’ mean JT interval
Dofetilide infusion significantly prolonged the
mean JT interval measured in 40 consecutive cardiac
cycles irrespective of the presence or absence of the
sinus rhythm (the ‘absolute’ mean JT) in both the
‘TdP+’ and ‘TdP-’ groups of animals, but there was
no statistical difference in the JT intervals between
the ‘TdP+’ and ‘TdP-’ groups of animals at any time
point of the measurement (Figure 7D).
Characterization of the arrhythmic beats
during dofetilide administration
The arrhythmic beats immediately before TdP in the
‘TdP+’ group of animals were significantly more
variable in terms of coupling interval and shape
than those measured at equivalent time point in the
‘TdP-’ group of animals; the within-animal standard
deviations of the coupling interval, R voltage and
QRS duration measured from the last 40 arrhythmic
beats before TdP were significantly greater in the
‘TdP+’ group of animals than in the ‘TdP-’ group of
animals (Figure 8). No such difference was seen
between the ‘TdP+’ and ‘TdP-’ groups of animals
when the first 40 arrhythmic beats after the start of
dofetilide infusion were analysed. The within-
animal mean coupling interval, R voltage and the
QRS duration of the arrhythmic beats did not differ
between the ‘TdP+’ and ‘TdP-’ groups of animals at
any time point of the measurement.
Assessing vagal nerve activity: ‘heart rate
variability’ and BRS in sinus rhythm
The computerized ‘heart rate variability’ analysis
produced quantitatively and qualitatively similar
data to that gained with the manual measurement
of 40 consecutive RR intervals (see above and
Table 3), that is, ‘sinus’ RR variability parameters did
not differ statistically between the ‘TdP+’ and the
‘TdP-’ groups at baseline and during the phenyle-
Table 3
The ‘sinus’ and ‘absolute’ beat-to-beat variability and instability of the RR interval in anaesthetized rabbits
n MeanRR SD RMS RMSSD SDSD TI STI
Sinus TdP-
Baseline 10 221  8 1.6  0.1 221  8 1.8  0.1 1.9  0.1 1.9  0.2 1.0  0.1
Phe 8 259  14‡ 2.3  0.5 259  14‡ 2.2  0.2 2.3  0.2 2.7  0.6 1.0  0.1
Dof 8 264  15‡ 2.3  0.4 264  15‡ 2.4  0.4 2.4  0.4 2.8  0.6 1.2  0.2
TdP+
Baseline 20 215  5 1.8  0.2 215  2 1.8  0.1 1.8  0.1 2.1  0.2 0.9  0.1
Phe 13 265  11‡ 2.8  0.5 265  11‡ 3.0  0.7 3.1  0.7 3.4  0.7 1.7  0.5
Dof 12 270  11‡ 3.1  0.5‡ 270  11‡ 3.6  0.7‡ 3.6  0.7‡ 4.0  0.8‡ 1.9  0.5‡
Absolute TdP-
Phe 10 257  11 13.4  7.2 258  11 19.9  2.6 20.2  12 11.3  5.8 7.2  5.4
Dof 10 259  12 18.1  7.9 260  12 31.8  14.2 32.2  14 21.5  10.8 17.4  8.6
Bef TdP 10 273  11 46.9  9.5#† 279  12#† 81.3  17.4# 82.3  17.7#† 60.3  13.5# 50.1  12.8#†
TdP+
Phe 20 262  7 22.6  4.9 263  7 39.5  9.2 40.1  9.4 24.5  6.1 22.6  6.2
Dof 20 265  7 38.5  5.6# 269  7 67.9  10.2# 68.8  10.3# 44.3  7.8*# 39.8  7.5*#
Bef TdP 20 291  17#† 71.5  5.9*#† 300  17#† 106.1  9.4#† 107.4  9.5#† 76.9  8.4#† 53.0  6.9#†
All values shown as means  SEM. For further details, see Figure 1 and Table 1.
*P < 0.05 versus ‘TdP-’ group, Kruskal–Wallis test.
‡P < 0.05 versus baseline.
#P < 0.05 versus Phe.
†P < 0.05 versus Dof, Wilcoxon test.
Sinus, the beat-to-beat variability and instability of the RR interval when measured in sinus rhythm; Absolute, the beat-to-beat variability and
instability of the RR interval when arrhythmias were involved in the measurement; n, number of animals in which the RR variability and
instability were determined (sinus variability and instability were determined only when there was sinus rhythm at the time point of the
measurement); MeanRR, the mean of the measured 40 consecutive RR intervals (ms); SD, the standard deviation of the measured 40
consecutive RR intervals (ms); RMS, the root mean square of the RR intervals (ms); RMSSD, the root mean square of the successive differences
of the RR intervals (ms); SDSD, standard deviation of successive differences of the RR intervals (ms); TI, total instability of the RR intervals (ms);
STI, short-term instability of the RR intervals (ms).
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phrine infusion (data not shown). However, in the
‘TdP+’ group of animals, there was a significant
increase in heart rate variability during dofetilide
infusion as compared with the baseline (Table 3,
‘sinus’ beat-to-beat variability parameters of the RR
interval), which indicates that vagal nerve activity
increased during drug infusion before TdP occurred.
No such increase was detected in the ‘TdP-’ group of
animals.
The mean up-baroreflex sensitivity (up-BRS) was
slightly, but non-significantly higher at all predeter-
mined time points in the ‘TdP+’ group as compared
with the respective values in the ‘TdP-’ negative
group. However, when only a single between-group
analysis was performed using the pooled BRS data
on all five 1-min time periods during the phenyle-
phrine infusion, a significantly higher up-BRS was
found in the ‘TdP+’ group than in the ‘TdP-’ group
(Table 5). There was no statistical difference in the
down-BRS between the ‘TdP+’ and the ‘TdP-’ groups
at any time point of the measurement (data not
shown).
Assessing sympathetic activity in
sinus rhythm
The mid-frequency spectral power of the systolic
arterial pressure, which is a good marker of the sym-
pathetic activity in sinus rhythm, did not differ sig-
nificantly between the ‘TdP+’ and ‘TdP-’ groups at
baseline [10.1  4.8 vs. 7.4  2.7 (mmHg)2 respec-
tively] and during phenylephrine infusion [6.4 
3.0 vs. 3.7  1.6 (mmHg)2 respectively].
Blood gases and serum ion levels
The blood gases and the serum levels of K+, Na+ and
Ca2+ were in the physiological range at baseline,
during the phenylephrine infusion and at the begin-
ning of the dofetilide infusion; there were no statis-
tical differences in the serum levels of K+, Na+ or
Ca2+, or the serum pH+ or blood gas values between
the ‘TdP+’ and the ‘TdP-’ groups at baseline, during
the phenylephrine infusion and at the beginning of
the dofetilide infusion (data not shown).
Discussion
Dofetilide prolonged the repolarization and induced
a large number of arrhythmias prior to TdP in our
study. Data showed that ‘preceding’ arrhythmias
may play a significant role in the genesis of TdP in
anaesthetized, a1-adrenoceptor-stimulated rabbits.
The arrhythmic beats immediately before TdP in the
Table 4
The ‘sinus’ and ‘absolute’ beat-to-beat variability and instability of the QT interval in anaesthetized rabbits
n MeanQT SD RMS RMSSD SDSD TI STI
Sinus TdP-
Baseline 10 167  6 5.6  0.4 168  6 6.6  0.5 6.5  0.5 6.6  0.7 3.3  0.3
Phe 8 185  12‡ 5.8  0.4 185  12‡ 8.1  0.8 7.8  0.6 7.2  0.7 3.8  0.4
Dof 8 207  10‡ 7.9  0.8 208  10‡ 10.4  2.4‡ 9.6  1.2‡ 8.9  1.0 3.9  0.6
TdP+
Baseline 20 169  4 5.3  0.4 169  4 6.7  0.5 6.3  0.4 6.2  0.6 2.8  0.2
Phe 13 192  7‡ 7.1  0.7‡ 192  7‡ 9.2  0.9‡ 8.4  0.5‡ 8.2  0.7 4.2  0.4‡
Dof 12 193  7‡ 7.2  0.8‡ 193  7‡ 8.6  1.1‡ 8.6  1.1‡ 8.5  1.1 3.8  0.3‡
Absolute TdP-
Phe 10 190  9 8.7  1.6 190  9 12.1  2.6 12.3  2.6 10.0  1.9 5.5  1.2
Dof 10 190  6 14.1  3.4 191  6 21.7  7.0 22.0  7.1 16.3  5.6 12.1  5.3
Bef TdP 10 232  7#† 19.0  2.8# 233  7#† 28.9  4.6# 29.2  4.7# 24.0  4.1# 15.3  3.1#
TdP+
Phe 20 195  5 10.9  1.3 195  5 16.3  2.6 16.5  2.6 12.7  1.9 8.5  1.7
Dof 20 205  5* 21.7  3.4# 206  5*# 34.4  6.2# 34.9  6.3# 23.3  4.1# 17.7  4.2#
Bef TdP 20 258  11#† 34.3  2.6*#† 260  11*#† 45.1  3.5*# 45.7  3.5*# 37.4  2.8*#† 21.8  1.5*#
All values shown as means  SEM. For further details, see Figure 1 and Tables 1 and 3.
*P < 0.05 versus ‘TdP-’ group, Kruskal–Wallis test.
‡P < 0.05 versus baseline.
#P < 0.05 versus Phe.
†P < 0.05 versus Dof, Wilcoxon test.
BJPBiomarkers of torsades de pointes liability
British Journal of Pharmacology (2010) 161 1477–1495 1487
‘TdP+’ group of animals were significantly more
variable in terms of coupling interval and shape
than those measured in the ‘TdP-’ group of animals
at equivalent time point. Accordingly, the ‘absolute’
beat-to-beat variability and instability parameters of
the ECG intervals were significantly elevated in the
‘TdP+’ group of animals immediately before TdP
onset (Tables 3 and 4 and Figures 5–7). Our data
indicate that in the setting of prolonged repolariza-
tion the more chaotic the ventricular rhythm, the
Figure 5
The ‘sinus’ and ‘absolute’ beat-to-beat variability and instability of the RR interval in anaesthetized rabbits. Sinus (figures on the left side): the
beat-to-beat variability and instability of the RR interval when measured in sinus rhythm. Absolute (figures on the right side): the beat-to-beat
variability and instability of the RR interval when arrhythmias were involved in the measurement. RR STV, short-term variability of the RR intervals;
RR instability, instability of the RR intervals; RR LTV, long-term variability of the RR intervals (ms); RR LTI, long-term instability of the RR intervals
(ms). All values shown as means  SEM. *P < 0.05 versus the ‘TdP-’ group, Kruskal–Wallis test. #P < 0.05 Dof versus Phe, Wilcoxon test. The results
of within-group comparisons are shown only between the Phe and Dof time points. For further details, see Figures 1 and 4.
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greater the ‘absolute’ beat-to-beat variability and
instability of the ECG intervals and the probability
of TdP development.
Those animals that subsequently experienced
TdP had more responsive baroreflex during phenyle-
phrine infusion before dofetilide administration
and their heart rate variability significantly
increased during dofetilide infusion, which suggests
vagal nerve involvement in the genesis of TdP.
Dofetilide-induced TdP was not determined by
the baseline haemodynamics, repolarization proper-
ties, autonomic status, blood gases or serum ion
concentrations.
Preceding arrhythmias
In our study, dofetilide induced large number of
arrhythmias prior to TdP and not only the
number but also the complexity of these
Figure 6
The ‘sinus’ and ‘absolute’ beat-to-beat variability and instability of the QT interval in anaesthetized rabbits. All values shown as means  SEM.
*P < 0.05 versus the ‘TdP-’ group, Kruskal–Wallis test. #P < 0.05 Dof versus Phe, Wilcoxon test. The results of within-group comparisons are shown
only between the Phe and Dof time points. For further details, see Figures 1,4 and 5.
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Figure 7
The ‘absolute’ beat-to-beat variability of the QRS interval (A–C) and the JT interval (D–F), and the ‘absolute’ beat-to-beat variability and instability
of the ventricular electric diastolic interval (DI, G–I) in anaesthetized rabbits. Mean, the mean of the measured 40 consecutive QRS, JT or DIs. All
values shown as means  SEM. *P < 0.05 versus the ‘TdP-’ group, Kruskal–Wallis test. #P < 0.05 Dof versus Phe, Wilcoxon test. ‡P < 0.05 Bef TdP
versus Dof, Wilcoxon test. Within group comparisons were performed only with the QRS mean, the JT mean and the DI mean values (A, D and
G); the results of within-group comparisons are shown only among the Phe, Dof and Bef TdP time points. For further details, see Figures 1,4 and
5. Note that the ‘absolute’ instability, STI, LTI, TI, SD, SDSD, RMSSD parameters of the QRS and the JT intervals were significantly increased in the
‘TdP+’ group immediately before TdP occurrence as compared with the respective values in the ‘TdP-’ group (Kurskal–Wallis test, data not shown).
Apart from ‘absolute’ LTV and LTI, no other beat-to-beat variability and instability parameters of the DI differentiated between the ‘TdP+’ and
‘TdP-’ groups of animals (data not shown).
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‘preceding’ arrhythmias increased before TdP.
However, the cascade of ‘preceding’ arrhythmias
during the administration of the test drug is not
unique to our experimental settings. Ventricular
premature beats developing minutes before TdP
(Carlsson et al., 1992; 1993) and the cascade of
drug-induced arrhythmias prior to TdP onset were
reported in the anaesthetized rabbit model of TdP
(Buchanan et al., 1993; Lu et al., 2000; Farkas et al.,
2002; Philp et al., 2007) as well as in clinical studies
(Locati et al., 1995). Thus, the preceding arrhyth-
mias in our study probably did not critically
depend on the arrhythmogenic substrate provided
by the combination of phenylephrine infusion and
pentobarbital anaesthesia. Non-TdP type ventricu-
lar tachycardia preceded TdP occurrence and the
incidence of non-TdP type ventricular tachycardia
was significantly higher in the ‘TdP+’ group than in
the ‘TdP-’ group during dofetilide infusion, which
suggest that non-TdP type ventricular tachycardia
can serve as a biomarker of TdP in the applied
model.
The present study is the first that measured the
frequency and the multiplicity of the arrhythmias
prior to TdP and quantified the beat-to-beat electri-
cal instability caused by the ‘preceding’ arrhyth-
mias. The data indicate that in the setting of delayed
repolarization the more chaotic the ventricular
rhythm (arrhythmic beats and ‘absolute’ beat-to-
beat variability and instability), the greater the prob-
ability of TdP development. That is, ‘preceding’
arrhythmias have characteristics that permit predic-
tion of TdP occurrence. This has previously been
overlooked.
Figure 8
Characterization of the first 40 arrhythmic beats (ABs) after the start of dofetilide infusion (Dof 1st 40 ABs) and the last 40 ABs immediately before
torsades de pointes (TdP) occurred in the ‘TdP+’ group of animals or at an equivalent time point in the ‘TdP-’ group of animals (last 40 ABs Bef
TdP). Within-animal mean (mean) and within-animal standard deviation (SD) of the coupling intervals (CI), QRS intervals and R voltages calculated
from 40 ABs measured at the time point. *P < 0.05 versus the ‘TdP-’ group, Kruskal–Wallis test.
BJPBiomarkers of torsades de pointes liability
British Journal of Pharmacology (2010) 161 1477–1495 1491
Beat-to-beat variability of the QT interval in
sinus rhythm
Dynamic ECG beat-to-beat variability parameters,
such as instability or STV, have been proposed
recently as better surrogates than QT interval for
TdP (Shah and Hondeghem, 2005; Thomsen et al.,
2007). ‘Sinus’ QT STV did not predict TdP in our
study with a1-adrenoceptor-stimulated, anaesthe-
tized rabbits, which is in a good agreement with the
results of earlier studies utilizing the same model
(Michael et al., 2007; Farkas et al., 2008; Vincze
et al., 2008). However, Carlsson et al. (2009)
reported that dofetilide at a rate of
0.883 mg·kg-1·min-1 (vs. 20 mg·kg-1·min-1 in our
study) increased QT STV in sinus rhythm prior to
the occurrence of ventricular premature beats and
TdP in methoxamine-sensitized, a-chloralose-
anaesthetized rabbits. This suggests that the predic-
tive value of the ‘sinus’ beat-to-beat variability of
the QT interval in the rabbit model may depend on
the experimental conditions, for example, anaesthe-
sia, a1-adrenergic stimulant and rate of infusion of
the test drug.
‘Absolute’ beat-to-beat variability and
instability ECG interval parameters and
electrical instability
The novel ‘absolute’ variability and instability
parameters are determined by measuring the beat-
to-beat variability and instability of the ECG inter-
vals at precise times before the window for TdP
manifestation, even during the occurrence of ven-
tricular arrhythmias. Thus, ‘absolute’ variability and
instability parameters are able to quantify the beat-
to-beat electrical instability even during arrhyth-
mias. In our study, the ‘absolute’ beat-to-beat
variability and instability parameters differentiated
between the ‘TdP+’ and ‘TdP-’ groups of animals
and predicted TdP occurrence (Tables 3 and 4 and
Figures 5–7). The data showed that the predictive
sensitivity of these variables was greater than the
sensitivity of equivalent variables measured earlier,
during stable sinus rhythm. Beat-to-beat electrical
instability quantified by the novel ‘absolute’ vari-
ability and instability parameters may represent a
precise biomarker for TdP risk. This novel approach
may facilitate early rejection of hazardous candi-
dates in preclinical drug discovery. Moreover, the
data array indicates that the stochastic determinants
of TdP are manifested in the beat-to-beat variability
and instability of the ECG intervals immediately
prior to TdP manifestation, indicating a mechanistic
link.
‘Absolute’ beat-to-beat variability and
instability of the ECG intervals elaborates the
mechanism of TdP in rabbits
Dofetilide increased the ‘absolute’ beat-to-beat vari-
ability and instability of all measured ECG param-
eters indicating the development of chaotic
ventricular repolarization, conduction and multiple
ectopic activity. The electrical instability measured
by the ‘absolute’ beat-to-beat variability and insta-
bility of the ECG intervals correlated with the prob-
ability of TdP development in our model. Our data
suggest that the ‘absolute’ beat-to-beat variability
and instability parameters of the ECG intervals were
greatly affected by the multiplicity of the arrhyth-
mic beats in terms of number, coupling interval and
shape. Interestingly, immediately before TdP, the
number (frequency) of arrhythmic beats did not
differ between the ‘TdP+’ and the ‘TdP-’ groups of
Table 5
Baroreceptor sensitivity before dofetilide administration in anaesthetized rabbits
Baseline Phe3 Phe6 Phe9 Phe12 Phe15 Phe total
TdP- Up-BRS 1.66  0.31 1.76  0.23 2.07  0.34 1.81  0.38 2.29  1.01 1.85  0.63 1.95  0.24
n = 9 n = 10 n = 9 n = 9 n = 8 n = 8 K = 44
TdP+ Up-BRS 1.83  0.32 1.86  0.24 2.24  0.32 2.42  0.29 2.56  0.92 2.59  0.46 2.27  0.14*
n = 16 n = 19 n = 17 n = 14 n = 14 n = 7 K = 71
All values shown as means  SEM. For further details, see Figure 1 and Table 1.
*P < 0.05 versus ‘TdP-’ group, Kruskal–Wallis test.
Up-BRS, the mean baroreceptor sensitivity [ms·(mmHg)-1] measured in spontaneous sequences of constantly widening RR interval as a result
of rises in the systolic arterial blood pressure; Baseline, baseline baroreflex sensitivity (BRS) determined by spontaneous up-BRS sequences
found in the 5-min period before the start of phenylephrine infusion; Phe3, Phe6, Phe9, Phe12 and Phe15, BRS determined by spontaneous
up-BRS sequences found in the last 1-min period of the phenylephrine infusion at a rate of 3, 6, 9, 12 and 15 mg·kg-1·min-1 respectively; Phe
total, the pooled BRS data of Phe3, Phe6, Phe9, Phe12 and Phe15. n, number of animals in which spontaneous up-BRS sequences were
determined at the time point of the measurement; K, the cumulative number of 1-min periods in which spontaneous up-BRS sequences were
measured during stepwise elevation of the phenylephrine infusion rate.
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animals. Nevertheless, at same time point immedi-
ately before TdP, the arrhythmic beats were signifi-
cantly more variable in terms of coupling interval
and shape in the ‘TdP+’ group of animals than in the
‘TdP-’ group of animals. It is widely accepted that
the site of origin determines the electrocardio-
graphic shape of the ectopic beat. Thus, our data
suggest that immediately before TdP, the number of
sites of origin of the arrhythmic beats in the ‘TdP+’
group of animals was greater than that in the ‘TdP-’
group of animals at equivalent time point. Vos et al.
(2000) suggested that multiple ventricular ectopic
beats contributed to TdP development by increasing
spatial dispersion of repolarization in chronic
atrioventricular-blocked dogs in vivo. However, that
study did not examine the relationship between TdP
development and the multiplicity of the ectopic
beats in terms of coupling interval and the shape.
Our data indicate that in the setting of prolonged
repolarization the more sites (myocardial cells) pro-
ducing ectopic beats in the heart in an unsynchro-
nized way with different coupling intervals, the
greater the ‘absolute’ beat-to-beat variability and
instability of the ECG intervals and the probability
of TdP development.
According to the most widely accepted theory,
the mechanism of TdP initiation (trigger) involves
an early afterdepolarization-induced ectopic beat,
while the mechanism of the arrhythmia mainte-
nance (substrate) involves re-entry circuits produced
by an increase in spatial dispersion of the repolar-
ization of the ventricular wall (Antzelevitch, 2007).
Earlier investigations showed that single and mul-
tiple premature beats may increase spatial inhomo-
geneity of repolarization (Laurita et al., 1998; Vos
et al., 2000), thus the dofetilide-induced cascade of
the ‘preceding’ arrhythmias might enhance the
spatial dispersion and produced an ideal substrate
for re-entrant arrhythmias, for example, TdP. Fur-
thermore, immediately before TdP, the coupling
intervals of the arrhythmic beats were more variable
in the ‘TdP+’ group than those in the ‘TdP-’ group
of animals. This implies that a greater variability in
coupling intervals provides a greater probability
that one of the ectopic beats can work as a trigger by
falling in the vulnerable period of the existing
re-entry circuits. The electrophysiological substrate
produced by the ‘preceding’ arrhythmias may
be the link between drug-induced early after-
depolarizations and TdP in the anaesthetized,
a1-adrenergically stimulated rabbit model of TdP.
Vagal nerve activity contributes to
drug-induced TdP in rabbits
In the present study, heart rate variability signifi-
cantly increased from baseline in the ‘TdP+’ group
of animals before TdP during simultaneous admin-
istration of phenylephrine and dofetilide, which
indicates vagal nerve activation prior to TdP
occurrence. Furthermore, phenylephrine infusion
increased significantly the up-BRS in all of the
animals before dofetilide infusion, but the increase
was significantly higher in the ‘TdP+’ group, which
indicates that the vagal nerve (and the baroreflex)
was more responsive to the rise in blood pressure in
the animals experiencing TdP than that in the
animals not developing TdP. Nevertheless, the
reason for the observed increase in vagal nerve
activity in the ‘TdP+’ group of animals and the role
of the vagal nerve activity in TdP development need
further investigations to clarify.
Phenylephrine induces bradycardia via activa-
tion of the baroreflex resulting in an increase in
vagal nerve activity and a reduction in cardiac sym-
pathetic activity in pentobarbital-anaesthetized
rabbits (Farkas et al., 2008). Importantly, as the
present study shows, although bradycardia makes
the heart susceptible to drug-induced TdP,
phenylephrine-induced bradycardia was not the key
factor for TdP induction, as heart rate did not differ
between the ‘TdP+’ and the ‘TdP-’ groups.
Recently, we reported that vagotomy prevented
clofilium-induced TdP in a1-adrenoceptor-
stimulated, pentobarbital-anaesthetized rabbits
(Farkas et al., 2008). Likewise, inhalation of formal-
dehyde vapour initiated TdP in conscious,
dofetilide-treated rabbits with a mechanism involv-
ing reflex co-activation of the parasympathetic and
the sympathetic outflows to the heart (Nalivaiko
et al., 2004). These earlier studies and our present
heart rate variability and BRS results imply that
vagal nerve activity may contribute to the develop-
ment of drug-induced TdP.
Sympathetic activity
In our study, the parasympathetic and sympathetic
activities of the animals were estimated only in
long, uninterrupted periods of sinus rhythm, as the
methods required. According to our results, the
sympathetic activity during sinus rhythm did not
predict TdP occurrence. However, it is widely
accepted that an increased sympathetic activity may
contribute to the genesis of TdP (Verrier and Antz-
elevitch, 2004). The progressive increase in the fre-
quency of arrhythmic beats and the ‘absolute’ beat-
to-beat variability and instability of the RR interval
during dofetilide infusion shows that the number of
arrhythmic beats and the irregularity of the ven-
tricular rhythm progressively increased in the ‘TdP+’
group prior to TdP occurrence. In humans, ventricu-
lar premature beats were consistently followed by a
burst of sympathetic nerve activation (Welch et al.,
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1989). Furthermore, it has been shown recently that
greater degrees of the irregularity of the ventricular
rhythm caused greater sympathoexcitation (Seger-
son et al., 2007). As premature ventricular beats
occurred frequently and the irregularity of the
ventricular rhythm progressively increased in the
animals before TdP, we cannot exclude the possibil-
ity that sympathetic activity contributed to
dofetilide-induced TdP in our study.
Conclusion
‘Preceding’ arrhythmias have characteristics that
permit prediction of TdP occurrence: the more
chaotic the ventricular rhythm, the greater the
probability of TdP initiation. This suggests that
complexity of the arrhythmic beats may play an
important mechanistic role in TdP genesis. The
beat-to-beat electrical instability quantified by the
novel ‘absolute’ variability and instability param-
eters correlates with the probability of TdP occur-
rence in our model. Furthermore, baroreflex and
vagal nerve activity may contribute to dofetilide-
induced TdP in the applied in vivo model.
Acknowledgements
Mr Gábor Komáromi is acknowledged for his help
with calculation of the beat-to-beat variability and
instability parameters. Dr Michael J. Curtis (King’s
College, London, UK) is thanked for his helpful
comments on the manuscript. The generous gift
of dofetilide by Gedeon Richter PLC. (Budapest,
Hungary) is gratefully acknowledged. This work was
supported by the Hungarian Ministry of Health [ETT
203/2003, 353/2006]; the Hungarian National
Research Fund [OTKA F-046776, OTKA K-69018,
NI-61902]; the National Research and Development
Programmes [NKFP 1A/046/2004]; and the Hungar-




Alexander SP, Mathie A, Peters JA (2009). Guide to
Receptors and Channels (GRAC), 4th edn. Br J
Pharmacol 158 (Suppl. 1): S1–S254.
Antzelevitch C (2007). Ionic, molecular, and cellular
bases of QT-interval prolongation and torsade de
pointes. Europace 9 (Suppl. 4): iv4–iv15.
Batey AJ, Coker SJ (2002). Proarrhythmic potential of
halofantrine, terfenadine and clofilium in a modified in
vivo model of torsade de pointes. Br J Pharmacol 135:
1003–1012.
Buchanan LV, Kabell G, Brunden MN, Gibson JK (1993).
Comparative assessment of ibutilide, d-sotalol, clofilium,
E-4031, and UK-68,798 in a rabbit model of
proarrhythmia. J Cardiovasc Pharmacol 22: 540–549.
Carlsson L, Almgren O, Duker G (1990).
QTU-prolongation and torsades de pointes induced by
putative class III antiarrhythmic agents in the rabbit:
etiology and interventions. J Cardiovasc Pharmacol 16:
276–285.
Carlsson L, Abrahamsson C, Drews L, Duker G (1992).
Antiarrhythmic effects of potassium channel openers in
rhythm abnormalities related to delayed repolarization.
Circulation 85: 1491–1500.
Carlsson L, Drews L, Duker G, Schiller-Linhardt G
(1993). Attenuation of proarrhythmias related to
delayed repolarization by low-dose lidocaine in the
anesthetized rabbit. J Pharmacol Exp Ther 267:
1076–1080.
Carlsson L, Andersson B, Linhardt G, Lofberg L (2009).
Assessment of the ion channel-blocking profile of the
novel combined ion channel blocker AZD1305 and its
proarrhythmic potential versus dofetilide in the
methoxamine-sensitized rabbit in vivo. J Cardiovasc
Pharmacol 54: 82–89.
Farkas A, Leprán I, Papp JG (1998). Comparison of the
antiarrhythmic and the proarrhythmic effect of
almokalant in anaesthetised rabbits. Eur J Pharmacol
346: 245–253.
Farkas A, Leprán I, Papp JG (2002). Proarrhythmic
effects of intravenous quinidine, amiodarone, d-sotalol,
and almokalant in the anesthetized rabbit model of
torsade de pointes. J Cardiovasc Pharmacol 39: 287–297.
Farkas A, Batey AJ, Coker SJ (2004). How to measure
electrocardiographic QT interval in the anaesthetized
rabbit. J Pharmacol Toxicol Methods 50: 175–185.
Farkas A, Dempster J, Coker SJ (2008). Importance of
vagally mediated bradycardia for the induction of
torsade de pointes in an in vivo model. Br J Pharmacol
154: 958–970.
Farkas AS, Nattel S (2010). Minimizing
repolarization-related proarrhythmic risk in drug
development and clinical practice. Drugs 70: 573–603.
Farkas AS, Acsai K, Tóth A, Dézsi L, Orosz S, Forster T
et al. (2006). Importance of extracardiac a1-adrenoceptor
stimulation in assisting dofetilide to induce torsade de
pointes in rabbit hearts. Eur J Pharmacol 537: 118–125.
Farkas AS, Makra P, Csík N, Orosz S, Shattock MJ,
Fülöp F et al. (2009). The role of the Na+/Ca2+ exchanger,
INa and ICaL in the genesis of dofetilide-induced torsades
de pointes in isolated, AV-blocked rabbit hearts. Br J
Pharmacol 156: 920–932.
BJP AS Farkas et al.
1494 British Journal of Pharmacology (2010) 161 1477–1495
Hondeghem LM, Carlsson L, Duker G (2001). Instability
and triangulation of the action potential predict serious
proarrhythmia, but action potential duration
prolongation is antiarrhythmic. Circulation 103:
2004–2013.
Laurita KR, Girouard SD, Akar FG, Rosenbaum DS
(1998). Modulated dispersion explains changes in
arrhythmia vulnerability during premature stimulation
of the heart. Circulation 98: 2774–2780.
van der Linde H, Van de Water A, Loots W,
Van Deuren B, Lu HR, Van Ammel K et al. (2005). A new
method to calculate the beat-to-beat instability of QT
duration in drug-induced long QT in anesthetized dogs.
J Pharmacol Toxicol Methods 52: 168–177.
Locati EH, Maison-Blanche P, Dejode P, Cauchemez B,
Coumel P (1995). Spontaneous sequences of onset of
torsade de pointes in patients with acquired prolonged
repolarization: quantitative analysis of Holter
recordings. J Am Coll Cardiol 25: 1564–1575.
Lu HR, Remeysen P, De Clerck F (2000). Nonselective
I(Kr)-blockers do not induce torsades de pointes in the
anesthetized rabbit during a1-adrenoceptor stimulation.
J Cardiovasc Pharmacol 36: 728–736.
Michael G, Dempster J, Kane KA, Coker SJ (2007).
Potentiation of E-4031-induced torsade de pointes by
HMR1556 or ATX-II is not predicted by action potential
short-term variability or triangulation. Br J Pharmacol
152: 1215–1227.
Nalivaiko E, De Pasquale CG, Blessing WW (2004).
Ventricular arrhythmias triggered by alerting stimuli in
conscious rabbits pre-treated with dofetilide. Basic Res
Cardiol 99: 142–151.
Nemec J, Hejlik JB, Shen WK, Ackerman MJ (2003).
Catecholamine-induced T-wave lability in congenital
long QT syndrome: a novel phenomenon associated
with syncope and cardiac arrest. Mayo Clin Proc 78:
40–50.
Pedersen HS, Elming H, Seibaek M, Burchardt H,
Brendorp B, Torp-Pedersen C et al. (2007). Risk factors
and predictors of Torsade de pointes ventricular
tachycardia in patients with left ventricular systolic
dysfunction receiving Dofetilide. Am J Cardiol 100:
876–880.
Philp KL, Hart G, Coker SJ (2007). A
gender-independent proarrhythmic action of
17beta-estradiol in anaesthetized rabbits. Eur J
Pharmacol 575: 113–121.
Pugsley MK, Authier S, Curtis MJ (2008). Principles of
safety pharmacology. Br J Pharmacol 154: 1382–1399.
Segerson NM, Sharma N, Smith ML, Wasmund SL,
Kowal RC, Abedin M et al. (2007). The effects of rate
and irregularity on sympathetic nerve activity in human
subjects. Heart Rhythm 4: 20–26.
Shah RR, Hondeghem LM (2005). Refining detection of
drug-induced proarrhythmia: QT interval and TRIaD.
Heart Rhythm 2: 758–772.
Thomsen MB, Verduyn SC, Stengl M, Beekman JD,
de Pater G, van Opstal J et al. (2004). Increased
short-term variability of repolarization predicts
d-sotalol-induced torsades de pointes in dogs.
Circulation 110: 2453–2459.
Thomsen MB, Oros A, Schoenmakers M, van Opstal JM,
Maas JN, Beekman JD et al. (2007). Proarrhythmic
electrical remodelling is associated with increased
beat-to-beat variability of repolarisation. Cardiovasc Res
73: 521–530.
Verrier RL, Antzelevitch C (2004). Autonomic aspects of
arrhythmogenesis: the enduring and the new. Curr
Opin Cardiol 19: 2–11.
Vincze D, Farkas AS, Rudas L, Makra P, Csík N, Leprán I
et al. (2008). Relevance of anaesthesia for
dofetilide-induced torsades de pointes in
a1-adrenoceptor-stimulated rabbits. Br J Pharmacol 153:
75–89.
Vos MA, Gorenek B, Verduyn SC, van der Hulst FF,
Leunissen JD, Dohmen L et al. (2000). Observations on
the onset of torsade de pointes arrhythmias in the
acquired long QT syndrome. Cardiovasc Res 48:
421–429.
Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF,
Janse MJ, Yellon DM et al. (1988). The Lambeth
Conventions: guidelines for the study of arrhythmias in
ischaemia infarction, and reperfusion. Cardiovasc Res
22: 447–455.
Welch WJ, Smith ML, Rea RF, Bauernfeind RA,
Eckberg DL (1989). Enhancement of sympathetic nerve
activity by single premature ventricular beats in
humans. J Am Coll Cardiol 13: 69–75.
BJPBiomarkers of torsades de pointes liability
British Journal of Pharmacology (2010) 161 1477–1495 1495
